Re-operations on the proximal thoracic aorta: results and predictors of short- and long-term mortality in a series of 174 patients

Abstract

Short- and long-term survival was satisfactory being excellent in patients with degenerative aneurysms and dismal in those with active endocarditis. Extensive aortic resections did not increase hospital mortality and were associated with a reduced need for aortic re-interventions. CPB time remains the most important risk factor for reduced survival in aortic surgery.

Outcomes of Aortic Root Replacement After Previous Aortic Root Replacement: The “True” Redo Root

“…In this series, despite a higher prevalence of preexisting comorbidities in the redo group (Table 1), we were able to achieve excellent results with in-hospital mortality, stroke, and dialysis rates of 5% or less that were not statistically different from the de novo group (Table 4). Previously published series of redo root replacement show a perioperative mortality in the range of 0% to 12% [4,5,11,[15][16][17]19]; however, most of these studies were small and mixed with patients who were not "true" redo root replacements.…”

Asaccular Aneurysm of the Ascending Aorta Following Coronary Artery Bypass Graft Surgery

“…There are several treatment options. Open surgery with aortic graft replacement has 6.9-15.4% in hospital mortality [3]. Thrombin embolization or coiling may lead to cerebral embolization or migration.…”

“…The clinical presentation of a false aneurysms of the ascending aorta are persistent infection and systemic embolization, bleeding, fistula, compression, orerosion of the surrounding structures. Open surgical repair of the saccular aneurysm of the ascending aorta has highrisks and mortality rate (ranges between 6.9% and 15.4%) [3]. The saccular aneurysms of the ascending aorta are more prone to rupture, for this reason repair at smaller diameters is recommended when diagnosed.…”

Endovascular Repair of Ascending Aortic Pseudoaneurysm With Custom-Designed Endograft

“…R egardless of the type of lesion, reoperations for ascending aortic pseudoaneurysm (AscAP) entail a hospital mortality rate of 6.9% to 15.4% [1,2]. Standard thoracic or abdominal aortic endografts (EGs) have been used off-label in very selected cases, but currently their use is challenged by the anatomic landmarks, complex anatomy, and hemodynamic forces of the ascending aorta [3,4].…”